Yesterday @WCMEnglanderIPM Director @ElementoLab (right) and @Degreesofhealth (left) hosted staff from the offices of @SenSchumer @SenGillibrand @NydiaVelazquez @RepDanGoldman @RepJeffries @NYSenator_JSS @LiuNewYork @CMJulieMenin @SeawrightForNY @RagaForQueens for a lab tour!

🧪💡 Predicting clinical trial success isn’t sci-fi anymore. New post: how HINT → SPOT → CTO → TrialPanorama are laying the foundation for agentic AI systems that can reason about trial outcomes in real time. The future of trial intelligence is autonomous, data-rich, and

In the second installment of Ecosystems: Avalanche, we explore its journey from the $13B TVL highs of 2021 to building for institutions today, with @CamiRusso, @luigidemeo, @cryptofishx, @euler_mab & @BenqiFinance. What does it mean to build something that lasts? Watch now👉

Congratulations Dr. Elemento (@ElementoLab)!

Our next @WCMEnglanderIPM #PrecisionMedicine Research Conference, "Precision Medicine in #BreastCancer," will be presented Thursday at 1 pm by Dr. Vered Stearns (@VeredStearns), pls join us via Zoom or in person!

Excited to share the first post in our new “Keiji AI Research Story” series. This one highlights our work on TrialGPT, a generative AI system for patient-to-trial matching, recently published in Nature Communications. TrialGPT is the first AI agent workflow built to match

The future of medicine must be collaborative, data-driven, and deeply human,” says Dean Robert A. Harrington (@HeartBobH). From AI to equity, we must train physicians to lead with empathy and innovation. The next 25 years start now.

Congratulations to @WCMEnglanderIPM's Chief Research Officer Dr. Bishoy Faltas (@FaltasLab) on being awarded tenure! "The next chapter is about asking bigger questions and building new bridges, between science and medicine, and between people!" https://t.co/qz6AKyLE9G

From my appearance on 60 Minutes: Me: Research works. If you want to freeze society where it is, then cripple the research enterprise. Bill Whitaker of 60 Minutes: Is that whole idea being lost in the harsh rhetoric by the administration? Me: The attack on universities is a

DECAF trial: continued consumption of caffeinated coffee was associated with a 39% lower risk of AF/AFL recurrence at 6 months after cardioversion vs. abstinence from coffee. View the slides here: https://t.co/zHib2T5gL0

Stop by the Health Innovation Pavilion #AHA25 @AHAScience Great stuff. Shark Tank competition. Entrepreneurs. Panels. Science and technology to help improve health.

Wonderful summary resource from @CancerResearch @ay_zhou et al: The global landscape of cancer cell therapies, clinical trial trends and emerging directions https://t.co/v5YDLlBDbB @NatRevDrugDisc

The prisoner’s dilemma in A.I. healthcare— when rational A.I. use leads to harmful outcomes Our new piece @TheLancet w/@pranavrajpurkar and Michael Moritz https://t.co/wdq7AvZJ6d

Interested in #ProstateCancer research? If so, read our @WCMEnglanderIPM colleague @DrScottTagawa's interview with @TargetedOnc on Lutetium Lu 177 vipivotide tetraxetan significantly enhancing survival in #mHSPC when combined with standard therapies. https://t.co/uvj56nxu4A

Very inspiring story about four siblings diagnosed with an incurable brain condition called Chiari malformation who were successfully treated by pediatric neurosurgeon Dr. Jeffrey Greenfield, an @WCMEnglanderIPM member. https://t.co/CXrg3yo87B

During a live event, @WCMEnglanderIPM Clinical Director Dr. Cora N. Sternberg (@cnsternberg) discussed the development of androgen receptor pathway inhibitors and takeaways from the ARANOTE trial in hormone-sensitive #ProstateCancer, with @TargetedOnc. https://t.co/XAzSMfj4n3

Dr. Juan Miguel Mosquera and colleagues from @WCMCPathology & @WCMEnglanderIPM @WeillCornell are proud to share the acceptance of eleven (11!) abstracts at @USCAP2026, including collaborations with @Isabl_io and @BostonGeneCorp

We encourage WCM clinicians, researchers & trainees to sign-up today for @WCMEnglanderIPM's bi-weekly one-hour #AI Clinic sessions to help you master advanced #AI tools like @claudeai @ChatGPTapp @XBench_Gemini and more! #CareDiscoverTeach #BigData #LLM https://t.co/F30VmUp5im

Don't miss the new meta-analysis in @Oncology_Ther that evaluated event-free survival (#EFS) as a surrogate endpoint for #OS in neoadjuvant-treated Muscle- Invasive #BladderCancer by @WCMEnglanderIPM Clinical Director Dr. Cora N. Sternberg (@cnsternberg)! https://t.co/lpnv9V9HGl

Trump AI Czar Says 'No Federal Bailout For AI' After OpenAI CFO's Comments

Cuban’s Stelara biosimilar: ~$1.4K vs $150K. A quiet revolution in drug pricing.